Retrospective Analysis of Allogeneic Hematopoietic Cell Transplant (HCT) Outcomes in Older Patients (≥70 Years) with Fludarabine/Melphalan (Flu/Mel) Conditioning Regimen and Tacrolimus/Sirolimus (Tac/Siro)-Based Graft-Versus-Host Disease (GVHD) Prophylaxis

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Amandeep Salhotra, Gabriel Park, Dongyun Yang, Sally Mokhtari, Diana Knobler, Ahmed M. Aribi, Vaibhav Agrawal, Ibrahim Taha Aldoss, Firoozeh Sahebi, Karamjeet Sandhu, Haris Ali, Shukaib Arslan
+15 more Brian J. Ball, Paul Koller, Hoda Pourhassan, Amanda L. Blackmon, Sunmin Park, Idoroenyi Usua Amanam, Pamela Sue Becker, Vinod A. Pullarkat, Eileen Smith, Stephen J. Forman, Guido Marcucci, Anthony Selwyn Stein, Monzr M. Al Malki, Andrew S. Artz, Ryotaro Nakamura
DOI: 10.1016/j.jtct.2025.12.190
Cited by: 0

Fields of Study & Subjects

Hematopoietic Stem Cell Transplantation Acute Myeloid Leukemia Research Renal Transplantation Outcomes and Treatments

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S141–S141
Publication date
1 February 2026
Language
EN